(Medical Xpress)—A team of researchers affiliated with several institutions in Japan is reporting that they have successfully transplanted tissue derived from human embryonic stem cells into monkey models of the eye disease, ...
Retinal implants that deliver longer pulses of electrical current may noticeably improve image sharpness for individuals who have lost their sight due to retinitis pigmentosa, according to a new study by researchers from ...
Dec 16, 2015
1
228
Retinitis pigmentosa is a progressive blindness that affects more than one million people worldwide. A subtype of the disease is caused by mutations in genes that produce proteins responsible for maturation of RNA, known ...
Nov 5, 2015
0
14
Scientists at the University of Manchester have successfully restored the sight of laboratory mice suffering from a common cause of blindness in people.
Sep 2, 2015
0
1305
Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI's Gavin Herbert Eye Institute and ...
Aug 13, 2015
0
4023
A receptor that is already a target for treating neurodegenerative disease also appears to play a key role in supporting the retina, scientists report.
Aug 10, 2015
0
110
A collaboration between scientists in the UK and the USA has shown that gene therapy can give life-long protection to the light-sensitive photoreceptor cells responsible for colour vision in a mouse model of the most common ...
Jul 15, 2015
0
66
Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous ...
Jul 2, 2015
0
58
The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of the device that restores vision in those blinded by a rare, degenerative ...
Jun 23, 2015
0
107
A new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound—and a powerful way to quickly test whether other molecules can have a positive ...
Jun 17, 2015
0
70
